TP53 and pancreatic neoplasm: MDM2 expression has been activated through the Ras—Raf—MEK pathway [16, 32], but the inverse relationship between MDM2 and p53 levels has not been observed in our study and in pancreatic cancer cell lines with mutant p53 [16].